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Dear Editor:
Ulcerative colitis (UC) is a chronic
inflammatory disorder of the colon
with a clinical course characterized
by periods of exacerbation and re-
mission. Its aetiology is unknown,
although genetic, environmental, in-
fectious and immunological factors
are thought to be involved. In UC,
data seem insufficient to characterize
the T-helper (Th) cell cytokine phe-
notype as either Th1 or Th2, even
though there is more evidence of
antibody-mediated hypersensitivity
in tissue damaging, and less evidence
of Th1 cell responses. UC is associ-
ated with a variety of extraintestinal
manifestations (EIMs) and up to one-
third of patients experience at least
one in their lifetime. The most fre-
quent EIM in UC is an arthritis in-
cluded among the seronegative
spondyloarthropathies (SpA), which
is characterized by inflammatory ax-
ial spine disease, asymmetric periph-
eral arthritis and enthesopathy. Few
studies have been performed to es-
tablish the profile of pro-inflamma-
tory cytokines in SpA, and a Th
predominance has not yet been dem-
onstrated, even though the efficacy of
anti-TNF-alpha treatment and other
indirect evidence suggest a Th1 im-
plication. Pyoderma gangrenosum
(PG) is a dermatologic manifestation
seen in about 0.5–5% of UC patients.
There are four prototypic forms of
PG (ulcerative, pustular, bullous and
vegetative), but even in PG the Th
profile has not yet been clarified. In
this report, we describe the case of a
UC patient who showed the consec-
utive occurrence of allergic
rhinoconjunctivitis, SpA and PG over
a period of 10 years.
A 14-year-old boy presented to the
Gastroenterology Unit in November
1991 with a 1-year history of UC.
He had been subjected to tonsillec-
tomy and adenoidectomy at the age
of 6 years. The pan-colonoscopy
showed an active pancolitis and bi-
opsy confirmed the diagnosis. Over
the next 4 years he was admitted to
the hospital on four occasions for
moderate to severe activity of the
intestinal disease. The therapy was
established according to the clinical
course of UC and was based on
chronic administration of mesalazine.
Corticosteroids were added to
aminosalicylates when needed. At the
age of 16, he started to smoke regu-
larly 10 cigarettes per day. In 1993 he
underwent an allergologic evaluation
for the presence of an increasing pe-
rennial rhinoconjunctivitis that had
started at the age of 12 with a mild,
intermittent clinical profile. He was
subjected to skin prick testing (SPT)
with a panel of common, local
allergens. The patient showed a more
intense positive SPT response to
mites than to histamine (positive
control). Total serum IgE levels were
452 mg/l (normal range 12–240 mg/l),
and the circulating eosinophil count
was 220 cells/ml (normal count
80
<500 cells/ml). Allergic rhinocon-
junctivitis was confirmed after a
challenge test and treated with anti-
histamine drugs, topical corticoste-
roid and ophthalmic preparations.
No injection immunotherapy was
planned. Over the next 6 years we
noted an improvement in the allergic
symptoms, which gradually disap-
peared, together with a slow im-
provement in the intestinal disease in
both severity and number of flare-
ups. An allergologic evaluation made
in June 1998 showed negative skin
reaction to the same SPT panel in the
presence of normal reactivity to his-
tamine. Total serum IgE levels fell
within the normal range (194 mg/l).
Eosinophil count was 140 cells/ml.
The allergologic status remained un-
modified during subsequent follow-
ups, and the pan-colonoscopy with
biopsy confirmed the remission of
UC. In October 1999, the patient was
observed at the Rheumatology Unit
with severe inflammatory polyarthri-
tis. A bone scintiscan examination
was performed after i.v. administra-
tion of 99mTc methylene diphospho-
nate (555 MBq), using a large-field
gamma camera (Starport 400 AT,
General Electric, Milwaukee, WI,
USA), to determine the distribution
and activity of the disease. The sac-
roiliac involvement was defined on
the basis of the sacroiliac/sacrum
uptake ratio as suggested by Percy
and Lentle [1]. The search for serum
rheumatoid factor was negative. Ar-
thritis was classified as seronegative
spondyloarthropathy, based on the
European Spondyloarthropathy Study
Group criteria, and required treatment
with methotrexate (10 mg/week). The
human leukocyte antigen (HLA)
haplotypes, tested with a microlym-
phocytotoxicity technique, showed
no particular rheumatologic suscep-
tibilities (A24, A28, B62, BW4,
BW6, CW3, CW7, DR11, DR13,
DR52, DQ7). In February 2000, the
patient was admitted to the Derma-
tologic Unit with a large ulcerative
pyoderma gangrenosum in the left
leg, which required a systemic treat-
ment with prednisone (40 mg/day)
and a local therapeutic option with
Castellani’s paint. At the same time,
there appeared in the right leg a small
follicular-based pustule (initial lesion
of PG) that did not break down and
rapidly disappeared.
The patient’s history showed the
occurrence of UC together with IgE-
mediated allergic disease. During the
course of UC, symptoms of atopy
disappeared at the same time as an
improvement in the intestinal disease,
while SpA and PG emerged. T-helper
lymphocytes have been shown to
play an important role in immune
responses, and at least three func-
tional subsets of Th cells have been
distinguished according to their cy-
tokine secretion profiles. Each subset
regulates the others in a dynamic
process. A prominence of one or
other of the Th1 and Th2 phenotypes
is described in several diseases, and
cross-regulation of the Th1 immune
response to suppress Th2 disease, or
vice versa, has been established in
human and animal models. Recently,
we have shown that UC atopic dis-
eases and SpA, as well as atopic
diseases and allergic contact derma-
titis (ACD), are strongly polarized
immunological conditions tending
to mutual exclusion, while SpA and
ACD may coexist. To explain the
mutual exclusion of atopic diseases
and SpA or ACD, and the coexistence
of SpA and ACD, we have postulated
that the diseases might lie at opposite
or equal ends of the immunological
spectrum according to T-helper cell
responses. It should be noted that
atopy is a well-known Th2 condition,
while in ACD the Th1 subtype pre-
dominates.
The clinical course shown by our
patient seems to indicate high Th2
activity at the beginning of his med-
ical history. In contrast, the late onset
of SpA and PG, together with a better
course of intestinal disease and the
disappearance of atopy symptoms,
suggests that immunological changes,
promoting Th1 manifestations, oc-
curred later in the course of UC.
These results clearly indicate dy-
namic changes in the immune re-
sponse in our patient. From a dy-
namic point of view, the immune
system could express over time, at
the individual level, different re-
sponses according to the prevalent Th
profile, as found in a patient with
rheumatoid arthritis. In particular, our
case possibly represents the clinical
expression of the linear differentia-
tion model postulated for lymphocyte
development. In this model, Th2
represents an immature pattern that,
through a Th0 stadium, terminally
differentiates along type-1 effector
cells. In fact, our patient, after de-
veloping UC together with rhino-
conjunctivitis, and after a period of
remission of both diseases, showed
arthritis and PG. Unfortunately, the
stimuli promoting the Th1/Th2 bal-
ancing or alternation of different Th1/
Th2 polarized diseases in vivo remain
far from clear. Recently, we have
demonstrated that cigarette smoking
and appendectomy are risk factors for
the development of EIMs in patients
with UC. In our case, the patient was
exposed to both risk factors, which
may have contributed to a T-helper
profile modification over time.
The development of these con-
cepts will not only allow a better
understanding of the mechanisms
involved in the pathogenesis and
course of UC, but will also provide
the basis for the development of
novel strategies for its treatment.
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